$0.06 0.00 (0%)
2/9/2012 3:57 PM

Alfacell Corp (NASDAQOTH:ACEL.PK)

CAPS Rating: 5 out of 5

A biopharmaceutical company, primarily engaged in the discovery and development of a new therapeutic class of drugs for the treatment of cancer and other pathological conditions.

Featured Broker Partners


Advertisement